Phase I Trial of Brentuximab Vedotin for Children with Recurrent or Refractory Hodgkin's Lymphoma or Systemic Anaplastic Large Cell Lymphoma
PEDIATRIC BLOOD & CANCER(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
PEDIATRIC BLOOD & CANCER(2019)